Tag: affordability

Ignagni: Health plan-provider partnership is the secret to sustainable, affordable care

As the U.S. health care industry undergoes tremendous transformation, partnerships and interdependence among all health care organizations will drive affordability and quality. That was a major theme today at the National Forum on Hospitals, Health Systems and Population Health in Washington, D.C. – and a message that America’s Health Insurance Plans President and CEO Karen Ignagni drove home in a keynote address. Continue reading

Posted in: Issue Alert

When the claim of ‘innovation’ is simply higher prices

High prices fuel the fire of innovation – that’s the misleading explanation drug companies give for setting their prices at astronomical levels. It’s also the explanation that Memorial Sloan Kettering’s Peter Bach, M.D., easily disproves in a new Forbes article. Continue reading

Posted in: Health Care Costs, Issue Alert

Politico Pro: Backlash builds over soaring drug prices

With a wave of new treatments carrying six-figure price tags in the pipeline, pressure is building on drugmakers to lower their prices, according to a new Politico Pro article. Continue reading

Posted in: Health Care Costs, Issue Alert

AHIP statement on Harvoni

America’s Health Insurance Plans (AHIP) Spokesman Brendan Buck released the following statement today after Gilead Sciences announced its newly approved hepatitis C drug Harvoni will be priced at $94,500 for a course of treatment. Continue reading

Posted in: Cost Alert, Health Care Costs

Any willing provider laws grab headlines in South Dakota

Any willing provider (AWP) laws – which allow any doctor or hospital to enter into a plan network – are making headlines thanks to a proposal on the ballot in South Dakota that would institute an AWP law and could prompt other states to consider similar policies. Continue reading

Posted in: Health Care Costs, Issue Alert

Chart of the day: Price matters

A new Morning Consult poll should serve as yet another a wake-up call for drugmakers, pushing them to be part of the solution to unaffordable and unsustainable prescription drugs. Continue reading

Posted in: Health Care Costs, Issue Alert

7 things we learned at the Health Affairs briefing on specialty drugs

Specialty drugs took center stage at today’s Health Affairs event, which introduced research from the October issue titled “Specialty Pharmaceutical Spending and Policy.” Below are some highlights. Continue reading

Posted in: Health Care Costs

NEWSFLASH: Many High-Price Drugs Are Covered the Same as a Hospital Visit

Why do you cover drugs so differently than a trip to the hospital? That’s the cry often heard from drugmakers as they try to defend the astronomical prices for some of their products. But it knowingly misleads from the fact that these high-priced drugs are often administered and paid for through health plan medical benefits. Continue reading

Posted in: Health Care Costs, Issue Alert

Moment of Truth: Gilead Comes to a Pricing Decision Point

The eyes of the health care world – and prime time TV audiences – are focused this week on the high prices of many pharmaceutical drugs. And one looming decision will tell us whether the tide has turned in favor of sustainable pricing – or whether drugmakers still have their heads in the sand. Continue reading

Posted in: Cost Alert, Health Care Costs

Small Business Owners Speak Out Against the HIT

This year alone, the health insurance tax (HIT) is expected to total roughly $8 billion, undermining the goal of affordability by increasing the cost of coverage for individuals, small businesses, seniors enrolled in Medicare Advantage, and states that rely on Medicaid health plans to provide high-quality care. In particular, small business owners across the country have expressed concern about the HIT and how it will affect their businesses and employees. Continue reading

Posted in: Health Care Costs, Issue Alert